Literature DB >> 22390643

Atherosclerosis as an inflammatory disease.

Antonino Tuttolomondo1, Domenico Di Raimondo, Rosaria Pecoraro, Valentina Arnao, Antonio Pinto, Giuseppe Licata.   

Abstract

In many ways, atherosclerosis is a chronic inflammatory disorder and this issue is confirmed by recent investigations of that have focused on inflammation, providing new insight into mechanisms of disease. Several recent studies have addressed the role of chemokines in leukocyte accumulation in atherosclerosis, extending our knowledge and understanding of the complex and cell type-specific functions of chemokines in atherosclerosis. Activated T-lymphocytes within the atherosclerotic vessel wall express the CD40 ligand surface molecule, known to play a major role in several immunological pathways. In addition to activated T-lymphocytes, functional CD40 and CD40L are coexpressed by human vascular endothelial cells, smooth muscle cells and human macrophages in vitro as well as in situ in human atherosclerotic lesions. Recent studies indicate that CD40L activates atheroma-associated cells by promoting the expression of molecules thought to be involved in atherosclerosis, such as adhesion molecules, cytokines, matrix metalloproteinases, and tissue factor. Atherosclerosis starts with an innate immune response involving the recruitment and activation of monocytes macrophages that respond to an excessive accumulation of modified lipids within the arterial wall, followed by an adaptive immune response involving antigen-specific T lymphocytes. Effector T cells recognize modified auto-antigens such as oxidized LDL and heat shock proteins (i.e. HSP-60) that are presented by antigen-presenting cells such as macrophages or dendritic cells. The accumulation of inflammatory cells within the arterial wall leads to local production of chemokines, interleukins and proteases that enhance the influx of monocytes and lymphocytes, thereby promoting the progression of atherosclerotic lesions Recent reports have helped explain some of these questions by pointing to a role of contact dependent interaction between CD40 and CD40 ligand (CD40L, renamed CD154) as a stimulus for atheroma-associated cells. Also Macrophages play important roles in the progression of atherosclerosis by exhibiting unique characteristics under the various stimuli, evolving the plaque instability, thrombus formation and remodeling. Macrophage recruitment by abnormal endothelium over developing atherosclerotic plaques, is aided by endothelial expression of adhesion molecules (ICAM-1, VCAM, ELAM). The knowledge of atherosclerosis as an inflammatory disease offers the opportunity to develop novel therapeutic strategies targeting the inflammatory component of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390643     DOI: 10.2174/138161212802481237

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  96 in total

Review 1.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 2.  LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system.

Authors:  Steven L Gonias; W Marie Campana
Journal:  Am J Pathol       Date:  2013-10-12       Impact factor: 4.307

Review 3.  The NLRP3 inflammasome and stroke.

Authors:  Yeqing Tong; Zhi-Hong Ding; Fa-Xian Zhan; Li Cai; Xiaoxv Yin; Jin-Lian Ling; Jian-Jun Ye; Shuang-Yi Hou; Zuxun Lu; Zhi-Hong Wang; Jia-Fa Liu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 4.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

Review 5.  Impact of hyperlipidemia on alloimmunity.

Authors:  Jessamyn Bagley; Jin Yuan; John Iacomini
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

6.  Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.

Authors:  Pei Yu; Ting Xiong; Christine B Tenedero; Paul Lebeau; Ran Ni; Melissa E MacDonald; Peter L Gross; Richard C Austin; Bernardo L Trigatti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

7.  The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.

Authors:  Hengdao Liu; Dan Lin; Hong Xiang; Wei Chen; Shaoli Zhao; Hui Peng; Jie Yang; Pan Chen; Shuhua Chen; Hongwei Lu
Journal:  Exp Ther Med       Date:  2017-06-14       Impact factor: 2.447

8.  GWAS-Supported CRP Gene Polymorphisms and Functional Outcome of Large Artery Atherosclerotic Stroke in Han Chinese.

Authors:  Zusen Ye; Hao Zhang; Lingli Sun; Huan Cai; Yonggang Hao; Zongliang Xu; Zhizhong Zhang; Xinfeng Liu
Journal:  Neuromolecular Med       Date:  2018-03-19       Impact factor: 3.843

9.  Anti-Inflammatory Effects of an Extract from Pseudomonas aeruginosa and Its Purified Product 1-Hydroxyphenazine on RAW264.7 Cells.

Authors:  Jun Xiao; Aye Aye Thwe; Tingting Liu; Dafei Gong; Wanhua Lin; Changhua Shang; ZuJun Lu
Journal:  Curr Microbiol       Date:  2021-05-27       Impact factor: 2.188

10.  IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: the genetics of atherosclerotic disease Mexican study.

Authors:  Gilberto Vargas-Alarcón; Carlos Posadas-Romero; Teresa Villarreal-Molina; Edith Alvarez-León; Javier Angeles-Martinez; Rosalinda Posadas-Sanchez; Irma Monroy-Muñoz; Sergio Luna-Fuentes; Carmen González-Salazar; Julian Ramirez-Bello; Guillermo Cardoso-Saldaña; Aida Medina-Urrutia; Eric Kimura-Hayama
Journal:  J Interferon Cytokine Res       Date:  2014-02-19       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.